Triple negative breast cancer: Clinical characteristics in the different histological subtypes

被引:40
作者
Dreyer, Geertje [1 ]
Vandorpe, Thijs [2 ]
Smeets, Ann [2 ]
Forceville, Kathleen [1 ,2 ]
Brouwers, Barbara [1 ,2 ]
Neven, Patrick [2 ,3 ]
Janssens, Hilde [2 ,4 ]
Deraedt, Karen [2 ,5 ]
Moerman, Philippe [2 ,5 ]
Van Calster, Ben [6 ,7 ]
Christiaens, Marie-Rose [2 ]
Paridaens, Robert [1 ,2 ]
Wildiers, Hans [1 ,2 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Gen Med Oncol, Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Multidisciplinary Breast Ctr, Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Gynecol Oncol, Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Radiotherapy, Louvain, Belgium
[5] Katholieke Univ Leuven Hosp, Dept Pathol, Louvain, Belgium
[6] Katholieke Univ Leuven Hosp, Dept Elect Engn ESAT SCD, Louvain, Belgium
[7] Katholieke Univ Leuven Hosp, Leuvens Kankerinst, Louvain, Belgium
关键词
Breast cancer; Triple negative; Histology; Outcome; Lymph node involvement; Apocrine breast cancer; EXPRESSION; CARCINOMA; FEATURES; RECEPTOR; RELAPSE;
D O I
10.1016/j.breast.2013.01.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the clinical behavior of triple negative breast cancer (TNC), including age distribution, occurrence of LN (lymph node) invasion and prognosis in different histological subtypes. Methods: For this cohort study we used data on 476 patients with newly diagnosed TNC at the University Hospitals Leuven (Belgium) between 1999 and 2009. Of these, 395 received upfront surgery, 68 neo-adjuvant chemotherapy and 21 had metastases at diagnosis. Results: Apocrine and invasive lobular TNC occur more often in older patients compared to IDC-NOS. Of the primarily operated patients with TNC, 35.1% has pathological LN involvement. There were no significant differences in nodal invasion between different histological subtypes, but most subtypes contained few patients. In contrast to previous reports, 6/14 of apocrine TNC had LN involvement. Disease free survival (DFS) was different in different histological subtypes, but group sizes were insufficient to be able to draw firm conclusions. Within the histologically 'homogeneous' IDC-NOS group with primary surgery and outcome data (n = 300), DFS with 3.5 year median follow-up decreased with increasing age, but chemotherapy and radiotherapy were much less frequently given with increasing age. In multivariable analysis, lower age, presence of LN involvement, lack of administration of chemotherapy and radiotherapy were significant predictors of relapse. Conclusion: TNC is not a uniform disease. Different histological subtypes have different age distribution and behavior. The prognosis of the most common histological subgroup, IDC-NOS, is better in older patients, but this is counterbalanced by significantly decreased use of chemotherapy and radiotherapy. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:761 / 766
页数:6
相关论文
共 50 条
  • [31] Clinicopathological characters of triple negative breast cancer
    Zhou, Xin
    Liu, Qian
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (01) : 17 - 20
  • [32] Triple negative breast cancer
    Ressler S.
    Mlineritsch B.
    Greil R.
    memo - Magazine of European Medical Oncology, 2010, 3 (4) : 185 - 189
  • [33] TRIPLE NEGATIVE BREAST CANCER IN ELDERLY PATIENTS CLINICAL APPROACH
    Emanuele, Catania Vito
    Valentino, Failla Andrea
    Adriana, Lupo
    Maria, Giordano
    Sebastiano, Fichera Salvatore
    Corrado, Randazzo
    Fernando, Cammisuli
    ACTA MEDICA MEDITERRANEA, 2014, 30 (03): : 697 - 702
  • [34] Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
    Pascal Jézéquel
    Olivier Kerdraon
    Hubert Hondermarck
    Catherine Guérin-Charbonnel
    Hamza Lasla
    Wilfried Gouraud
    Jean-Luc Canon
    Andrea Gombos
    Florence Dalenc
    Suzette Delaloge
    Jérôme Lemonnier
    Delphine Loussouarn
    Véronique Verrièle
    Mario Campone
    Breast Cancer Research, 21
  • [35] Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers
    Choi, Junjeong
    Jung, Woo-Hee
    Koo, Ja Seung
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (11) : 1481 - 1493
  • [36] Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
    Dubrava, Alex L.
    Kyaw, Pan Su Pyae
    Newman, Joseph
    Pringle, Jarrad
    Westhuyzen, Justin
    Fuentes, Gina La Hera
    Shakespeare, Thomas P.
    Sakalkale, Renukadas
    Aherne, Noel J.
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 359 - 371
  • [37] Adjuvant therapy of triple negative breast cancer
    Perez, Edith A.
    Moreno-Aspitia, Alvaro
    Thompson, E. Aubrey
    Andorfer, Cathy A.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (02) : 285 - 291
  • [38] A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
    Tseng, Ling-Ming
    Chiu, Jen-Hwey
    Liu, Chun-Yu
    Tsai, Yi-Fang
    Wang, Yun-Lin
    Yang, Chu-Wen
    Shyr, Yi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (02) : 241 - 254
  • [39] Microelectrode bioimpedance analysis distinguishes basal and claudin-low subtypes of triple negative breast cancer cells
    Srinivasaraghavan, Vaishnavi
    Strobl, Jeannine
    Agah, Masoud
    BIOMEDICAL MICRODEVICES, 2015, 17 (04)
  • [40] The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease
    Andy Evans
    Yee Ting Sim
    Brooke Lawson
    Jane Macaskill
    Lee Jordan
    Alastair Thompson
    Breast Cancer, 2022, 29 : 296 - 301